Receive The Newest Study Notifications

ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, is pleased to announce a further update on progress with the ongoing Phase I/II clinical trial in the US of its hRPC cell therapy candidate in the blindness-causing...

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the first patient has been successfully dosed in a Phase I clinical trial of anti-cluster of...

Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that necessary documentation has been completed for the European Medicines Agency (EMA) March 15, 2019 submission cycle requesting...

Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) announced today the acceptance of an abstract for a late-breaker oral presentation at The International Liver Congress™ 2019, the Annual Meeting of the European Association for the Study of the Liver (EASL) in Vienna,...

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that it has now begun dosing patients in a...

A new study from researchers at Columbia University Vagelos College of Physicians and Surgeons shows that a drug given to some pregnant women to prevent severe respiratory ailments in preterm newborns reduces healthcare costs. Drug previously shown effective in...

Adlai Nortye Ltd.("Adlai Nortye"), a global clinical-stage biopharmaceutical company today released the animal model data of Buparlisib (AN2025) at the 7th ICHNO, the International Conference on Innovative Approaches in Head & Neck Oncology. The data suggests...

ImmunogenX is pleased to announce the initiation of a Phase 2 clinical trial (named Celiac Shield™), sponsored by the National Institutes of Health’s (NIH) National Center for Complementary and Integrative Health (NCCIH), to be conducted at the Mayo Clinic in...

- PDUFA Action Date Extended by Three Months to July 6, 2019 - - FDA Has Requested Additional Existing Information for Review - Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, today announced that the U.S. Food and Drug...

The Lupus Research Alliance (LRA) and the National Minority Quality Forum (NMQF) today released the insightful report, "Addressing the Challenges of Clinical Research Participation Among Populations Disproportionately Impacted by Lupus." The report presents findings...

PROPHECY validation trial published in Journal of Clinical Oncology  Epic Sciences, Inc. (Epic) today announced the publication of results from a multicenter prospective trial validating the biomarker AR-V7 (androgen receptor splice variant-7) as a predictor of...

Cheetah Medical, a Massachusetts-based leader in non-invasive fluid management, today announced it has concluded enrollment for the Fluid Responsiveness Evaluation in Sepsis-associated Hypotension (FRESH) trial following successful primary outcomes. The FRESH study,...

Largest clinical treatment study of 330 pediatric patients with Chagas disease Bayer presented results today from the CHICO part (CHagas disease In Children treated with NifurtimOx) of the phase III clinical study of investigational nifurtimox in pediatric patients...

Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced the first patients have been treated in the Company's second...

Not all successful trials require a large budget. It's still possible to run a high-quality clinical trial in a cost-effective manner from clinical operations costs to data management and biostatistics. Clinical trial recruitment company, Clinical Trial Media, explain...

Recent upgrades in international and domestic regulations regarding clinical trials, are both designed to protect patients, but also to upgrade the 'new normal' procedures in clinical trial quality and more efficient approaches to clinical trial design, conduct,...

Global, multi-center study led by Cleveland Clinic compare the benefits and risks of two common treatment approaches for relapsing-remitting multiple sclerosis Cleveland Clinic Lou Ruvo Center for Brain Health is now recruiting participants for a new,...

Company Announces Expanded Data From Troriluzole Phase IIb/III Long-Term Extension Study Compared To Matched Natural History Cohort Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative,...

Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women's health, today announces that it has successfully completed Phase 1a study of FOR-6219, an HSD17B1 inhibitor for the treatment of endometriosis. The randomised,...

Pulsed Shortwave Neuromodulation Therapy (ActiPatch®) Study in Chronic Lower Back Pain BioElectronics Corporation (OTC PINK: BIEL) http://www.bielcorp.comis pleased to announce the commencement of a clinical study investigating the efficacy of ActiPatch in treating...